News and Insights of 3D Printing and Manufacturing
Biotechnology firm United Therapeutics has showcased what it claims to be the “world’s most complex 3D printed object” in partnership with 3D printer manufacturer 3D Systems at the recent LIFE ITSELF conference in San Diego.
Israeli regenerative medicine firm Matricelf has reached a new milestone in the development of its 3D printed neural implants for paralyzed patients with spinal cord injuries.
Biotechnology firm Prellis Biologics has announced the closure of a $14.5 million Series B funding round alongside the creation of a novel antibody discovery platform.
Scientists from the Human Genome and Stem Cell Research Center (HUG-CELL) University of São Paulo (USP), have utilized 3D bioprinting to develop functional hepatic organoids, otherwise known as mini-livers.
San Francisco biotechnology company Prellis Biologics has launched a web-based platform for the generative design and download of 3D printable tissue scaffolds. Named TissueWorkshop™, the platform has been created to reduce the amount of time required to create such structures, freeing experts from labor-intensive design cycles.
California-headquartered medical imaging company QT Ultrasound has used its detailed pictures of microanatomy to 3D print a model of a woman’s breast tissue. A tangible model of the complex duct system, the model presents a potential avenue for diagnosticians working with breast cancer.
CollPlant Biotechnologies released a letter from its Chief Executive Officer, Yehiel Tal, to its shareholders. The letter summarizes a strong year for the company and its shareholders, which has benefitted from the uptick in 3D printing research and interest throughout 2020 to position itself for an even stronger 2021. The letter reads as follows:
Pandorum Technologies Pvt., a Bangalore-based biotechnology company, has used 3D bioprinted cornea tissue to promote scarless healing of wounds in the eye.
Korean biotechnology companies T&R Biofab and SCM Life Science are to collaborate on the R&D of new 3D printed tissue regenerative products. The two companies will focus on marketable cell patch products and new formulations for cell therapy.
Leading 3D printer OEM 3D Systems and Israeli bioprinting material developer CollPlant have announced a joint development agreement seeking to create tissue and scaffold bioprinting solutions for third party collaborators.